Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T06:06:12.520Z Has data issue: false hasContentIssue false
  • English
  • Français

S12.03 - Pharmacotherapy of sexual ofenders

Published online by Cambridge University Press:  16 April 2020

P. Briken
P. Briken*
Affiliation:
Institute of Sex Research and Forensic Psychiatry, Centre of Psychosocial Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background and Aims:

This lecture addresses testosterone-lowering and other psychotropic medications for the treatment of sexual offenders.

Methods:

Literature review.

Results and Conclusions:

Randomized controlled studies on pharmacological treatments for sexual offenders with the outcome criterion recidivism are still lacking. On the other hand, there is a substantial scientific knowledge about the wide range of psychiatric comorbidity in sexual offenders. Empirically-based treatment especially of impulsivity, anxiety and mood disorders in these patients may also ameliorate the sexual impulsivity. The prescription of testosterone lowering agents should be restricted to paraphilic sexual offenders with an at least moderate or high risk for hands on sexual offences and should always be combined with psychotherapy. The decision process for different treatment options will be described focusing on aspects of comorbidity, risk, and motivation.

Type
Symposium: Assessment and treatment of sexual and violent offenders
Information
European Psychiatry , Volume 23 , Issue S2: 16th AEP Congress - Abstract book - 16th AEP Congress , April 2008 , pp. S21
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.